{"nct_id":"NCT06160609","title":"Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants With RRMM","status":"TERMINATED","status_verified_date":"2024-02","start_date":"2019-10-07","start_date_type":"ACTUAL","primary_completion_date":"2023-01-09","primary_completion_date_type":"ACTUAL","completion_date":"2023-01-09","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GSK"]}